Hakim CH, Burkin DJ, Duan D. Alpha 7 integrin preserves the function of the extensor digitorum longus muscle in dystrophin-null mice. J Appl Physiol 115: 1388 -1392. First published August 29, 2013 doi:10.1152/japplphysiol.00602.2013.-The dystrophin-associated glycoprotein complex (DGC) and the ␣ 7␤1-integrin complex are two independent protein complexes that link the extracellular matrix with the cytoskeleton in muscle cells. These associations stabilize the sarcolemma during force transmission. Loss of either one of these complexes leads to muscular dystrophy. Dystrophin is a major component of the DGC. Its absence results in Duchenne muscular dystrophy (DMD). Because ␣ 7-integrin overexpression has been shown to ameliorate muscle histopathology in mouse models of DMD, we hypothesize that the ␣ 7␤1-integrin complex can help preserve muscle function. To test this hypothesis, we evaluated muscle force, elasticity, and the viscous property of the extensor digitorum longus muscle in 19-day-old normal BL6, dystrophin-null mdx4cv, ␣ 7-integrin-null, and dystrophin/␣7-integrin double knockout mice. While nominal changes were found in single knockout mice, contractility and passive properties were significantly compromised in ␣ 7-integrin double knockout mice. Our results suggest that DGC and ␣ 7␤1-integrin complexes may compensate each other to maintain normal skeletal muscle function. ␣ 7␤1-Integrin upregulation may hold promise to treat not only histological, but also physiological, defects in DMD.
filament, while the extracellular domain interacts with laminin-221/221 in the muscle basal lamina. The ␣ 7 ␤ 1 -integrin complex constitutes another transsarcolemmal linkage connecting the cytoskeleton and the extracellular matrix (3, 7, 17) . Mutations in genes that encode components of these complexes lead to various forms of muscular dystrophy (6) . For example, mutation in the dystrophin gene causes Duchenne muscular dystrophy (DMD), the most common lethal inherited muscle wasting diseases (16) . Deficiency in the ␣ 7 -integrin gene causes congenital myopathy, a mild but progressive muscular dystrophy (13, 22) .
The molecular mechanisms of these muscular dystrophies are not fully understood. However, it is generally believed that weakened extracellular matrix-cytoskeleton interaction is a primary initiating event that starts a chain reaction of repeated cycles of muscle degeneration/regeneration and eventually myofiber necrosis and fibrosis. From this standpoint, strengthening extracellular matrix-cytoskeleton interaction may represent a promising therapeutic modality for treating DMD and ␣ 7 -integrin-deficient congenital myopathy. To explore this approach, our laboratory has previously tested whether transgenic overexpression of ␣ 7 -integrin can reduce muscle disease in utrophin/dystrophin double knockout (u-Dko) mice, a severe murine DMD model (4, 5) . Compared with transgene negative u-Dko mice, ␣ 7 -integrin transgenic mice showed significantly improved muscle histology. However, it is not clear whether forced ␣ 7 -integrin expression also enhances muscle function. More recently, we generated dystrophin/␣ 7 -integrin double null (␣ 7 I-Dko) mice (23) . These mice die prematurely between the ages of 16 and 26 days. Furthermore, they exhibit characteristic dystrophic muscle pathology, such as increased central nucleation and widespread inflammation (23) . Despite the well-characterized histological presentation, the physiological consequences of dystrophin/␣ 7 -integrin double deficiency have not been studied. As a matter of fact, very few studies have examined the impact of the ␣ 7 ␤ 1 -integrin complex on muscle function.
To address this question, we examined the contractile and the passive (elastic and viscous) properties of the extensor digitorum longus (EDL) muscle in 19-day-old normal, dystrophin-null mdx4cv, ␣ 7 -integrin-null, and ␣ 7 I-Dko mice. As expected, mice lacking both dystrophin and ␣ 7 -integrin showed much severe histopathology (8, 23) . Importantly, compared with other strains, the specific force was significantly reduced in ␣ 7 I-Dko mice. Muscle compliance and viscous property were also significantly altered in ␣ 7 I-Dko mice. Our results suggest that the ␣ 7 ␤ 1 -integrin complex is crucial for maintaining normal skeletal muscle function. Strategies aimed at increasing ␣ 7 -integrin expression may preserve not only muscle structural integrity but also muscle function.
MATERIALS AND METHODS

Experimental mice.
All animal experiments were approved by the Animal Care and Use Committee of the University of Missouri and were in accordance with National Institutes of Health guidelines. Normal control C57Bl/6 (BL6) and BL6 background dystrophindeficient mdx4cv mice were purchased from The Jackson Laboratory (Bar Harbor, ME). The ␣ 7-integrin knockout (␣7I-ko) mice were on the BL6 background, and their generation has been published before (22) . The ␣ 7I-Dko mice were generated by interbreeding mdx4cv and ␣7I-ko mice. Progeny mice were genotyped for dystrophin and ␣7-integrin by PCR, as previously described (23, 24) . For all experiments, 19-day-old male mice were used. All experimental mice were housed in a specific pathogen-free facility and with free access to food and water. Sample size is provided in Table 1 .
Histology and immunostaining. Morphological examinations were performed on freshly isolated EDL muscles that had not been subjected to muscle function assay. General histopathology was determined by hematoxylin and eosin (HE) staining. Myofiber centronucleation and myofiber size were determined from an HE-stained muscle section. Masson trichrome staining was used to examine fibrosis (19) . Dystrophin was detected using Dys-2, a monoclonal antibody specific for the dystrophin COOH-terminal domain (1:20; Vector Laboratories, Burlingame, CA). ␣ 7-Integrin was detected with a rabbit polyclonal antibody (1:200) (21) .
Evaluation of the contractile and passive properties of the EDL muscle. Experimental mice were anesthetized via intraperitoneal injection of a cocktail containing 25 mg/ml ketamine, 2.5 mg/ml xylazine, and 0.5 mg/ml acepromazine at 2.5 l/g body wt. The EDL muscle was prepared for physiology assay, as previously described (11, 12) . Briefly, while they were viewed through a stereomicroscope (Nikon, Melville, NY), the hindlimb muscles were exposed, and the tibialis anterior muscle was gently removed. The distal and proximal EDL tendons were tied with a 6 -0 suture (SofSilk USSC Sutures, Norwalk, CT) at the myotendinous junction. The intact EDL muscle was gently dissected and vertically mounted in an organ bath (Aurora Scientific, Aurora, ON, Canada). Throughout the dissection procedure, the mouse body temperature was maintained at 37°C using a radiant heat lamp, and all exposed muscles were constantly superfused with prewarmed Ringer buffer. The optimal length (L o) of the EDL muscle was determined at the maximal isometric twitch force (Pt). The absolute Pt and tetanic force (Po), as well as the time to peak tension and half relaxation time of the maximal tetanic contraction were recorded to determine the contractile property of the EDL muscle (9, 12) . The muscle cross-sectional area (CSA) was calculated according to the following formula: (muscle mass, in g)/[(optimal fiber length, in cm) ϫ (1.06 g/cm 3 )]. The value 1.06 g/cm 3 is the muscle density. The specific Pt and Po were obtained by dividing the value of the absolute force with the CSA (12) .
The passive performance was evaluated by the elastic and viscous properties of the muscle (10, 12) . The elastic property of the EDL muscle was determined using a six-step passive stretch protocol in the absence of electrical stimulation. At each step, the EDL muscle was passively stretched in an increment of 10% L o at a rate of 2 cm/s. The viscous property was determined by measuring the stress relaxation rate (SRR), while the muscle was stretched at 110% L o and held for 1.5 s (until passive stress reached the plateau). The SSR was calculated from the equation [(stress1 Ϫ stress2)/(time2 Ϫ time1)] using the following time frames: peak to 0.1 s post-peak (pp), 0.1 to 0.2 s pp, 0.2 to 0.5 s pp, 0.5 to 1 s pp, and 1 to 1.5 s pp. At the end of each experiment, the tendons were removed from the EDL muscle, and the muscle weight was determined. The CSA was calculated as previously described (11, 12) .
Statistical analysis. Data are presented as means Ϯ SE. Statistical significance among experimental groups was determined by one-way ANOVA analysis followed by Bonferroni post hoc analysis using the SPSS software (IBM, Armonk, NY). Difference was considered significant when P Ͻ 0.05.
RESULTS
Characterization of the ␣ 7 I-Dko mice. Since ␣ 7 I-Dko mice usually die within 1 mo after birth (8, 23) , we performed all the studies in 19-day-old mice. The genotype of every mouse strain was determined by PCR (Fig. 1D ). ␣ 7 I-Dko mice appeared much smaller, and their body weight was significantly reduced, compared with that of other strains (Fig. 1 , E and F, and Table 1 ). Muscle wasting was apparent only in ␣ 7 I-Dko mice (Fig. 1F) . The weight of the ␣ 7 I-Dko EDL muscle was significantly lower than that of other strains ( Table 1 ). The CSA of the ␣ 7 I-Dko EDL muscle was significantly smaller than that of the BL6 and ␣ 7 I-ko mice, but not that of mdx4cv mice (Table 1) .
Immunofluorescence staining and histology. As expected, dystrophin was localized at the sarcolemma in BL6 and ␣ 7 I-ko mice, but absent in mdx4cv and ␣ 7 I-Dko mice (Fig. 1A) . ␣7-Integrin was detected in BL6 and mdx4cv mice, but not ␣ 7 I-ko and ␣ 7 I-Dko mice (Fig. 1) . No apparent difference was observed in HE staining among BL6, mdx4cv, and ␣ 7 I-ko mice. They all displayed minimal central nucleation (Fig. 1, A  and B) . Clusters of central nucleated cells, mononucleated cells, and interstitial fibrosis were observed only in the ␣ 7 IDko muscle (Fig. 1, A and B) . To quantify dystrophic pathology, we determined the percentage of centrally nucleated myofibers. Compared with that of the other three strains, central nucleation was significantly increased in ␣ 7 I-Dko mice (Fig. 1B) . Myofiber diameter quantification yielded an interesting pattern (Fig. 1C) . The myofiber distribution curve showed a leftward shift in mdx4cv, ␣ 7 I-ko, and ␣ 7 I-Dko EDL muscles, indicating more large myofibers in these three strains (Fig. 1C) .
Contractile properties. P t and P o forces were similar among BL6, mdx4cv, and ␣ 7 I-ko mice (Table 1) . However, these values were reduced by ϳ50% in ␣ 7 I-Dko mice (Table 1) . Specific P t and P o (absolute force normalized by the CSA) were significantly decreased in ␣ 7 I-Dko mice in relative to the Values are means Ϯ SE; n, no. of mice. BL6, normal control; ␣7I-ko, ␣7-integrin knockout; ␣7I-Dko, ␣7-integrin/dystrophin double knockout; CSA, cross-sectional area; Pt, isometric twitch force; Po, tetanic force. *␣7I-Dko mice are significantly different from all other age-matched mouse strains. †␣7I-Dko mice are significantly different from age-matched BL6 and ␣7I-ko mice.
␣7I-Dko EDL Function • Hakim CH et al. other three strains (Fig. 2, A and B) . Interestingly, the time to peak tension and the half relaxation time showed no significant difference among all four strains (Fig. 2, C and D) .
Passive properties. To study the elastic property, we examined the stress-strain profile. Elimination of either ␣ 7 -integrin alone or dystrophin alone did not change muscle stiffness (Fig. 3A) . However, the stress-strain profile of the ␣ 7 I-Dko EDL muscle was significantly altered. It showed a significantly higher resistant force at the strain of 110% L o . Furthermore, the post-peak stress of the ␣ 7 I-Dko EDL muscle was significantly lower than that of other three strains. Interestingly, there was no significant difference in the peak stress among all experimental mice (Fig. 3B) .
To study the viscous property, we measured the SRR. The SRR of the ␣ 7 I-Dko mouse EDL muscle was significantly decreased compared with that of the other mouse strains in every time frame we studied.
DISCUSSION
DMD is an X-linked recessive severe muscle wasting disease that leads to premature death in boys. There is currently no cure for this malicious disease. Extensive efforts have been dedicated to develop novel strategies to treat DMD. Among these is ␣ 7 -integrin upregulation. Several lines of evidence support ␣ 7 -integrin-based therapy. First, upregulation of ␣ 7 -integrin has been observed in dystrophin-deficient mice and DMD patients, suggesting a possible compensatory response in the absence of dystrophin (15) . Second, genetic elimination of both dystrophin and ␣ 7 -integrin dramatically accelerates dystrophic process in mice (8, 23) . Third, transgenic overexpression of ␣ 7 -integrin effectively mitigated histopathology in the u-Dko mouse model of DMD (4, 5) . Collectively, published data suggest that the ␣ 7 ␤ 1 -integrin complex may help preserve structural integrity of dystrophin-deficient muscle. Since muscle pathology does not always correlate with muscle function (1, 18, 20) , it is imperative to determine whether the morphological benefit of ␣ 7 -integrin overexpression can also translate to muscle function improvement. Unfortunately, little is known about the role the ␣ 7 ␤ 1 -integrin complex plays in muscle function regulation.
The main goal of our study is to determine if the ␣ 7 ␤ 1 -integrin complex can help maintain normal skeletal muscle function. To achieve this goal, we compared muscle strength and the passive property in normal, dystrophin-null, ␣ 7 -integrin-null, and double null mice. We reasoned that, if the ␣ 7 ␤ 1 -integrin complex plays a similar role as the DGC complex in maintaining muscle function, then we should see ). An average of 1,000 fibers were counted for each mouse strain. C: quantification of the myofiber size (n ϭ 4). An average of 700 fibers was measured for each strain. D: representative genotyping results. Top: ␣7-integrin PCR. Wild type yields a 727-bp band and knockout yields a 482-bp band. Bottom: mdx4cv PCR. Wild type yields a 141-bp band, and knockout yields a 123-bp band. E: growth curve (mean body weight at the indicated age) of BL6 (n ϭ 10), mdx4cv (n ϭ 10), ␣7I-ko (n ϭ 6), and ␣7I-Dko (n ϭ 10) mice. F: a representative photograph of a normal and a ␣7I-Dko mouse at 19 days of age. *␣7I-Dko mice are significantly different from all other age-matched groups.
␣7I-Dko EDL Function • Hakim CH et al. the greatest function loss in double null mice. If the ␣ 7 ␤ 1 -integrin complex does not contribute to muscle force generation, elasticity, and viscosity, then double null mice should yield a similar profile as that of dystrophin null mice in physiology measurement. Consistent with previous reports (8, 23) , ␣ 7 I-Dko mice exhibited the phenotype of severe progressive muscular dystrophy ( Fig. 1) . At the age of 19 days, the body weight and the EDL muscle weight were significantly reduced (Fig. 1, E and F, and Table 1 ). There were also patches of inflammatory cell infiltration and interstitial fibrosis in the ␣ 7 I-Dko muscle (Fig.  1A) . Quantitatively, the ␣ 7 I-Dko muscle had a significantly much higher percentage of central nucleation than that of the other three strains. Compared with BL6 mice, there were also more large-size myofibers in ␣ 7 I-Dko mice (Fig. 1, B and C) . These results confirmed our laboratory's previous report that the ␣ 7 ␤ 1 -integrin complex plays a structural role in maintaining skeletal muscle integrity (23) .
EDL muscle function was assessed by measuring the contractile and the passive (elastic and viscous) properties. Eliminating dystrophin alone or ␣ 7 -integrin alone did not change P t and P o , neither did it change muscle CSA normalized specific P t and P o (Fig. 2, Table 1 ). In sharp contrast, muscle strength was significantly reduced in mice lacking both dystrophin and ␣ 7 -integrin (Fig. 2, Table 1) . Nevertheless, the time to peak tension and the half relaxation time were not altered in either single knockout or double knockout mice. Changes in the passive properties were unremarkable in mdx4cv and ␣ 7 I-ko mice (Fig. 3) . However, stress-strain curve and SRR were significantly compromised in ␣ 7 I-Dko mice. The ␣ 7 I-Dko EDL muscle was stiffer and more susceptible to failure than the EDL muscle of other strains. Also, the SRR was significantly reduced in the ␣ 7 I-Dko mice. Taken together, our results suggest that the ␣ 7 ␤ 1 -integrin complex and the DGC complex may represent two redundant systems in preserving normal muscle function. Functional deficiency caused by the loss of one complex can at least be partially compensated by the other complex. In support of our findings, a recent study showed that adeno-associated virus-mediated ␣ 7 -integrin expression can protect adult dystrophin-null mdx mice from eccentric contraction-induced force loss (14) .
In summary, our results suggest that, in addition to maintaining structural integrity, the ␣ 7 ␤ 1 -integrin complex also Eliminating both dystrophin and ␣7-integrin significantly reduces muscle contractility, but contraction kinetics are not altered in the EDL muscle. Muscle force in 19-day-old BL6 (n ϭ 10), mdx4cv (n ϭ 10), ␣7I-ko (n ϭ 6), and ␣7I-Dko (n ϭ 10) mice is shown. A and B: muscle cross-sectional area normalized isometric twitch (A) and tetanic (B) forces. C and D: the time to the maximum force (C) and half relaxation time (D) of the absolute tetanic force. *␣7I-Dko mice are significantly different from all other age-matched groups.
␣7I-Dko EDL Function • Hakim CH et al. plays a critical role in preserving skeletal muscle function. Upregulation of ␣ 7 -integrin may represent a viable strategy to ameliorate muscle pathology and improve muscle function in DMD patients.
